Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Published on by Global Scholar Awards

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Published on by Global Scholar Awards

Prof. Padmanabha Rao Amarachinta | Pharmacology and Nanotechnology | Leading Innovations in Science Award

Professor and Deputy Registrar at Anurag University, India

Dr. Padmanabha Rao Amarachinta, Professor and Deputy Registrar at Anurag University, Hyderabad, is a distinguished scholar in pharmaceutical sciences with over 23 years of experience in teaching, research, and industry. He holds a Ph.D. in Toxicology and has conducted advanced research at premier Indian institutions like IICT, CCMB, and NIN. Dr. Rao has published over 35 high-impact papers and authored several book chapters, notably in the area of nanomedicine. His innovations in drug delivery systems, particularly intranasal delivery of Rizatriptan, have earned him both Indian and German patents. He is a recipient of numerous awards including the “Distinguished Scientist Award” and “Leading Educationist of India.” His research interests include nanotechnology, drug discovery, and clinical research, and he is actively involved in mentoring Ph.D. scholars. Dr. Rao’s impactful contributions and leadership in pharmaceutical research make him a strong candidate for the Leading Innovations in Science Award.

Professional Profile 

Education🎓

Dr. Padmanabha Rao Amarachinta possesses a strong academic background in pharmaceutical sciences, culminating in a Ph.D. in Toxicology. His educational journey laid a solid foundation for his research and teaching career, with a focus on drug delivery systems and nanomedicine. Throughout his academic training, Dr. Rao demonstrated a keen interest in toxicology and pharmacology, which guided his doctoral research and subsequent scientific contributions. His advanced studies were complemented by research collaborations with prestigious Indian institutes such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and the National Institute of Nutrition (NIN), where he further deepened his expertise in biomedical sciences. His academic achievements reflect a rigorous and interdisciplinary approach to science, combining theoretical knowledge with practical research applications. Dr. Rao’s educational foundation continues to influence his innovative work in pharmaceutical technology, toxicology, and clinical research, enabling him to mentor scholars and contribute to cutting-edge scientific advancements.

Professional Experience📝

Dr. Padmanabha Rao Amarachinta brings over 17 years of diverse professional experience in academia and research, specializing in pharmaceutical sciences and toxicology. He has held significant academic positions, notably serving as an Associate Professor in the Department of Pharmacy at GITAM Deemed to be University. Dr. Rao has been instrumental in designing and delivering advanced curricula in pharmacology and toxicology, mentoring postgraduate and Ph.D. scholars, and fostering a research-driven academic environment. His professional journey includes collaborative research projects with prestigious institutions such as the Indian Institute of Chemical Technology (IICT), Centre for Cellular and Molecular Biology (CCMB), and National Institute of Nutrition (NIN). He has contributed to numerous national and international journals, reflecting his strong research acumen. Dr. Rao’s career highlights his commitment to academic excellence, interdisciplinary research, and innovation in drug delivery systems, making him a respected figure in both academic and scientific communities.

Research Interest🔎

Dr. Padmanabha Rao Amarachinta’s research interests lie primarily in the fields of pharmacology, toxicology, and drug delivery systems, with a special focus on the evaluation of herbal and synthetic drugs for their therapeutic efficacy and safety. He is particularly interested in the pharmacodynamic and pharmacokinetic profiling of novel drug candidates, including natural products with potential pharmacological activity. Dr. Rao explores innovative drug delivery mechanisms to enhance the bioavailability and targeted action of therapeutic agents, aiming to reduce side effects and improve patient outcomes. His research also delves into preclinical toxicological evaluations and the mechanisms of drug-induced organ toxicity. He is passionate about bridging traditional medicinal knowledge with modern pharmacological approaches through scientific validation of herbal formulations. With collaborations across premier research institutions, his work contributes significantly to advancements in evidence-based medicine and the development of safer, more effective treatment options for chronic and acute conditions.

Award and Honor🏆

Dr. Padmanabha Rao Amarachinta has received numerous awards and honors in recognition of his outstanding contributions to pharmaceutical sciences and academic excellence. He has been honored with prestigious fellowships and accolades from reputed institutions, highlighting his dedication to research and innovation in pharmacology and toxicology. Among his notable recognitions are awards for best research paper presentations at national and international conferences, acknowledging the scientific impact and quality of his work. He has also received institutional awards for his commitment to teaching and mentoring students, fostering a collaborative and intellectually stimulating academic environment. His contributions to the field have earned him invitations to serve as a keynote speaker and session chair at several scientific events. These honors reflect not only his professional achievements but also his influence in shaping the next generation of researchers and healthcare professionals, reinforcing his status as a respected figure in the pharmaceutical and biomedical research community.

Research Skill🔬

Dr. Padmanabha Rao Amarachinta possesses a comprehensive set of research skills that span across pharmaceutical sciences, pharmacology, and toxicology. His expertise lies in experimental design, data analysis, and interpretation, particularly in preclinical and in vitro models used for drug evaluation and safety profiling. He is highly skilled in molecular biology techniques, including PCR, ELISA, and Western blotting, which he employs in elucidating mechanisms of drug action and toxicity. Dr. Amarachinta is adept at handling laboratory instruments and software for statistical and bioinformatics analysis, facilitating accurate and reproducible research outcomes. His ability to draft scientific manuscripts, research proposals, and grant applications showcases his proficiency in academic writing and communication. Additionally, he has guided numerous postgraduate students, demonstrating his capability in mentoring and collaborative research. His methodical approach, critical thinking, and problem-solving abilities significantly contribute to his success in advancing pharmaceutical research and generating impactful scientific knowledge.

Conclusion💡

Dr. Padmanabha Rao Amarachinta exhibits strong qualifications for the Leading Innovations in Science Award. His deep-rooted contributions in nanomedicine, high-impact publications, international patents, and academic leadership make him a compelling nominee. He is a proven innovator in pharmaceutical sciences with an impressive blend of academic, research, and administrative excellence.

With minor emphasis on commercialization, global project leadership, and science communication, his already remarkable portfolio could be elevated to even greater heights.

Publications Top Noted✍️

  • Title: Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect
    Authors: PR Amarachinta, G Sharma, N Samed, AK Chettupalli, M Alle, JC Kim
    Year: 2021
    Citations: 77

  • Title: Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel
    Authors: AK Chettupalli, M Ananthula, PR Amarachinta, V Bakshi, VK Yata
    Year: 2021
    Citations: 51

  • Title: Pharmacological evaluation of herbal extracts for their in-vitro hypoglycemic activity
    Authors: AP Rao, KJ Kaiser Jamil
    Year: 2011
    Citations: 32

  • Title: Comparative toxicity of tetra ethyl lead and lead oxide to earthworms, Eisenia fetida (Savigny)
    Authors: JV Rao, P Kavitha, AP Rao
    Year: 2003
    Citations: 24

  • Title: Design, development and optimization of solid lipid nanoparticles of rizatriptan for intranasal delivery: in-vitro & in-vivo assessment
    Authors: V Bakshi, PR Amarachinta, AK Chettupalli
    Year: 2022
    Citations: 23

  • Title: Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations
    Authors: A Unnisa, AK Chettupalli, RS Alazragi, W Alelwani, AM Bannunah, …
    Year: 2023
    Citations: 17

  • Title: Development and validation of glibenclamide in nanoemulsion formulation by using RP-HPLC
    Authors: AB Mohd, P Swathimutyam, AP Rao, N Shastri, PV Diwan
    Year: 2011
    Citations: 15

  • Title: Method development and validation for estimation of risperidone in novel liquisolid formulation by RP-HPLC
    Authors: K Sanka, S Bairi, R Gullapelli, S Bandi, AM Babu, AP Rao, PV Divana
    Year: 2014
    Citations: 9

  • Title: Formulation and evaluation of poly herbal liqui-solid compact for its anti-inflammatory effect
    Authors: AK Chettupalli, RR Amara, PR Amarachinta, RM Manda, BSR Garige, …
    Year: 2021
    Citations: 8

  • Title: Development and validation of simvastatin in microemulsion formulation using RP-HPLC
    Authors: C Srinivas, AB Mohd, S Huidrom, A Rao, PV Diwan
    Year: 2012
    Citations: 8

  • Title: Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route
    Authors: AK Chettupalli, S Ajmera, PR Amarachinta, RM Manda, RK Jadi
    Year: 2023
    Citations: 6

  • Title: Preclinical evaluation of polyherbal formulations: hypoglycemic activity in rats
    Authors: PR Amarachinta, KJ Kaiser Jamil
    Year: 2012
    Citations: 6

  • Title: Letter to Editor: Recent Advancement in Blood Cancer Research and Management
    Authors: MA Jahangir, AP Rao
    Year: 2019
    Citations: 4

Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Published on by Global Scholar Awards

Assist. Prof. Dr.Mohsen Mehrabi | Pharmacology | Excellence in Academic-Industry Collaboration Award

Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, Iran

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at Shahroud University of Medical Sciences, with a Ph.D. in Medical Nanotechnology from Tehran University of Medical Sciences. His research focuses on drug and vaccine delivery systems, nanoparticles for wound healing, and nanofiber-based wound dressings. He has published extensively in high-impact journals, contributing significantly to biomedical advancements, particularly in chitosan-based vaccine delivery, essential oil nanoemulsions, and cancer therapies. With expertise in polymeric nanoparticles, niosomes, and phytosomes, his work bridges fundamental research and practical medical applications. Additionally, he holds an MBA in Strategic Management, enhancing his ability to lead interdisciplinary projects. Despite his strong academic record, increased international collaborations, patents, and industry partnerships could further amplify his impact. Dr. Mehrabi’s dedication to innovation in nanomedicine and consistent research output make him a strong candidate for the Best Researcher Award, recognizing his contributions to advancing medical sciences

Professional Profile 

Education

Dr. Mohsen Mehrabi has a diverse and multidisciplinary educational background in medical sciences and nanotechnology. He earned his Ph.D. in Medical Nanotechnology from the School of Advanced Medical Technology at Tehran University of Medical Sciences (2012-2018), where he specialized in nanoparticle-based vaccine delivery systems. Prior to that, he completed his M.Sc. in Medical Nanotechnology at the same institution (2008-2011), focusing on chitosan nanoparticles for drug delivery. He also pursued an MBA in Strategic Management at Tehran University (2021-2022), enhancing his expertise in research leadership and project management. His undergraduate education includes a B.Sc. in Medical Laboratory Sciences from Jondi Shapour Medical University of Ahvaz (2005-2007) and an Associate Degree in Medical Laboratory Sciences from Shiraz University of Medical Sciences (2001-2003). His strong academic foundation in nanomedicine, biotechnology, and medical sciences has significantly contributed to his research in drug delivery, vaccine development, and biomedical applications.

Professional Experience

Dr. Mohsen Mehrabi is an Assistant Professor of Medical Nanotechnology at the School of Medicine, Shahroud University of Medical Sciences (2018–present). With expertise in nanomedicine, drug delivery systems, and biomedical applications, he has played a key role in advancing research on nanoparticle-based drug and vaccine delivery, wound healing, and cancer therapies. His professional journey includes extensive academic research, supervision of scientific projects, and collaboration with international experts in the field of nanotechnology. His work on polymeric nanoparticles, niosomes, phytosomes, and hydrogel-based wound dressings has led to multiple high-impact publications. Additionally, his MBA in Strategic Management has equipped him with leadership and project management skills, allowing him to contribute to research strategy and innovation. Dr. Mehrabi’s dedication to interdisciplinary research and translational science has positioned him as a leading figure in medical nanotechnology, making significant contributions to both academic and applied biomedical research.

Research Interest

Dr. Mohsen Mehrabi’s research interests focus on nanotechnology-driven solutions for drug and vaccine delivery, wound healing, and biomedical applications. His work primarily explores polymeric nanoparticles (chitosan and alginate), niosomes, and phytosomes for targeted drug and vaccine delivery systems, aiming to enhance therapeutic efficacy and immunogenicity. He is particularly interested in the development of nanoparticle-based vaccine carriers, including chitosan-loaded recombinant hepatitis B antigen, to improve immune response. His research extends to essential oil nanoemulsions for antimicrobial and therapeutic applications in both human and veterinary medicine. Additionally, he investigates hydrogel-based nanoparticles for wound healing and nanofiber mesh as advanced wound dressings. His interdisciplinary approach integrates nanomedicine, biotechnology, and pharmaceutical sciences to develop innovative and efficient drug delivery systems. Through his work, Dr. Mehrabi aims to bridge the gap between fundamental nanoscience and clinical applications, contributing to advancements in precision medicine and targeted therapies.

Award and Honor

There is no specific information provided about awards and honors received by Dr. Mohsen Mehrabi. However, given his significant contributions to the field of medical nanotechnology, his extensive research on drug and vaccine delivery systems, and his numerous high-impact publications, he is a strong candidate for academic recognition and prestigious research awards. His work on chitosan-based nanoparticles, essential oil nanoemulsions, and hydrogel-based wound dressings has advanced biomedical applications, making a notable impact in nanomedicine and biotechnology. Additionally, his leadership in interdisciplinary research and his role as an Assistant Professor at Shahroud University of Medical Sciences further highlight his academic excellence. While specific accolades are not listed, his dedication, innovation, and contributions to medical sciences make him a potential recipient of awards recognizing excellence in nanotechnology, drug delivery, and vaccine research. Further details on awards and honors could strengthen his professional profile.

Research Skill

Dr. Mohsen Mehrabi possesses advanced research skills in medical nanotechnology, drug delivery systems, and biomedical applications. His expertise includes the design, synthesis, and characterization of polymeric nanoparticles such as chitosan, alginate, niosomes, and phytosomes for targeted drug and vaccine delivery. He has extensive experience in nanoparticle formulation, stability assessment, and in vitro/in vivo evaluation of drug-loaded systems. His skills extend to hydrogel-based wound dressings, nanofiber mesh fabrication, and essential oil nanoemulsions for therapeutic applications. He is proficient in physicochemical characterization techniques, including spectroscopy, electron microscopy, and chromatographic methods, to analyze nanoparticle properties and drug release profiles. His ability to integrate nanotechnology, immunology, and pharmaceutical sciences enables him to develop novel therapeutic strategies. Additionally, his strategic research planning and project management skills, supported by his MBA in Strategic Management, enhance his ability to lead interdisciplinary studies and contribute to cutting-edge innovations in nanomedicine.

Conclusion

Dr. Mohsen Mehrabi has a remarkable research record in nanomedicine and drug delivery, making him a strong contender for the Best Researcher Award. His work has significant scientific merit, real-world medical applications, and global relevance. Strengthening industry collaborations, patenting innovations, and increasing international leadership roles could further solidify his candidacy.

Publications Top Noted

  1. Title: Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat

    • Authors: Mahboubi Kancha M., Alizadeh M., Mehrabi M.
    • Year: 2024
    • Citation: 2

  2. Title: Isolation and Characterization of Extracellular Vesicles of Chick Embryo Blood

    • Authors: Rezakhania L., Gharibshahian M., Zamani S., Mehrabi M., Alizadeh M.
    • Year: 2024
    • Citation: 1

 

 

You said:
Craft compelling and forward-looking web content for the ‘Pharmacology’ Begin with a very short introduction and very short